3-Bromo-N-phenylbenzenesulfonamide is an intermediate in the synthesis of Belinostat Acid (B131485). Belinostat Acid is a metabolite of Belinostat (B131400), a novel histone deacetylase 3 selective inhibitor, which protects the β cells from cytokine-induced apoptosis.
